• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Recent Advances in the Study of 5-Chloro-4-methylbenzimidazole (CAS: 1360938-85-7)

5-Chloro-4-methylbenzimidazole (CAS: 1360938-85-7) is a benzimidazole derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its role as a key intermediate in the synthesis of bioactive compounds, particularly in the context of kinase inhibitors and antimicrobial agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential therapeutic applications.

One of the most notable advancements in the study of 5-Chloro-4-methylbenzimidazole is its incorporation into the design of novel kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with various diseases, including cancer and inflammatory disorders. Researchers have demonstrated that derivatives of 5-Chloro-4-methylbenzimidazole exhibit potent inhibitory activity against specific kinases, such as JAK2 and EGFR, which are implicated in oncogenic processes. These findings suggest that this compound could serve as a valuable scaffold for the development of targeted cancer therapies.

In addition to its potential in oncology, 5-Chloro-4-methylbenzimidazole has also been investigated for its antimicrobial properties. Recent studies have shown that this compound and its derivatives exhibit broad-spectrum activity against both Gram-positive and Gram-negative bacteria, as well as fungal pathogens. The mechanism of action appears to involve disruption of microbial cell wall synthesis and interference with essential enzymatic processes. These results highlight the compound's versatility and its potential as a starting point for the development of new antimicrobial agents in an era of increasing antibiotic resistance.

From a synthetic chemistry perspective, 5-Chloro-4-methylbenzimidazole has proven to be a highly versatile building block. Researchers have developed efficient and scalable synthetic routes to produce this compound, enabling its widespread use in medicinal chemistry campaigns. Recent publications have detailed innovative methods for functionalizing the benzimidazole core, allowing for the introduction of diverse substituents that modulate the compound's physicochemical and pharmacological properties. These advancements have significantly expanded the chemical space around 5-Chloro-4-methylbenzimidazole, opening new avenues for structure-activity relationship studies.

Despite these promising developments, challenges remain in the optimization of 5-Chloro-4-methylbenzimidazole-based compounds for clinical applications. Issues such as solubility, metabolic stability, and selectivity need to be addressed through further medicinal chemistry efforts. However, the growing body of research on this compound underscores its potential as a valuable tool in drug discovery. Future studies are expected to focus on the development of more potent and selective derivatives, as well as the exploration of their mechanisms of action at the molecular level.

In conclusion, 5-Chloro-4-methylbenzimidazole (CAS: 1360938-85-7) represents a promising scaffold in chemical biology and medicinal chemistry. Its applications span from kinase inhibition to antimicrobial activity, demonstrating its versatility as a building block for bioactive compounds. As research in this area continues to advance, it is anticipated that this compound will play an increasingly important role in the development of novel therapeutics for a range of diseases.

• 7495-32-1( )
• 221548-24-9(6-Chloro-2,5-dimethyl-1H-benzoDimidazole)
• 180508-09-2(6-chloro-4-methyl-1H-1,3-benzodiazole)
• 1456821-64-9(4-Methylbenzimidazole Hydrochloride)
• 109943-02-4(1H-Benzimidazole,6-chloro-5-methyl-)
• 67468-95-5(1H-Benzimidazol-2-amine, 5-chloro-6-methyl-)
• 893566-44-4(6-Chloro-7-methyl-1H-imidazo4,5-bpyridine)
• 935873-40-8(1H-Benzimidazole, 7-chloro-6-methyl-)
• 683240-82-6(2,6-dichloro-5-methyl-1H-1,3-benzodiazole)
• 626606-17-5(1H-Benzimidazole, 2-(2-chlorophenyl)-4-methyl-)